Detection of undiagnosed cases of diabetes type 2 in patients with risk factors at community pharmacies of Portugal

Authors

  • D PILGER Grupo de Investigación en Atención Farmacéutica (CTS-131). Universidad de Granada - Facultad de Farmacia
  • H SANTOS Grupo de Investigación en Atención Farmacéutica (CTS-131). Universidad de Granada - Facultad de Farmacia
  • MH FINO Grupo de Investigación en Atención Farmacéutica (CTS-131). Universidad de Granada - Facultad de Farmacia
  • MF CAETANO Grupo de Investigación en Atención Farmacéutica (CTS-131). Universidad de Granada - Facultad de Farmacia
  • MJ FAUS Grupo de Investigación en Atención Farmacéutica (CTS-131). Universidad de Granada - Facultad de Farmacia
  • P IGLÉSIAS Grupo de Investigación en Atención Farmacéutica (CTS-131). Universidad de Granada - Facultad de Farmacia

Keywords:

Diabetes type 2, Early diagnosis, Pharmaceutical services, Public health, Community pharmacy

Abstract

The aim of this study was to evaluate the applicability of a protocol to identify possible undiagnosed cases of diabetestype 2 in patients with risk factors at community pharmacies. Descriptive transversal study was done in eight communitypharmacies of Portugal. Participants were costumers over age 45 and presenting another risk factor for diabetestype 2. Characteristics were collected and capillary blood glucose was measured. Patients with high glycemia werereferred to the physician to get a diagnosis. 229 individuals presenting risk factors participated in the study, 32 (14%)suspected cases were identifi ed and referred to the physician. In 22 cases (68,7%) the diagnosis feedback was obtainedwith 12 diagnosed patients – positive predictive value 54,5%. The rate of detection was 5,4%. Suspected and diagnosedcases were identifi ed, thus the protocol to identify undiagnosed cases in patients with risk factors for diabetes type 2is recommended to be used in community pharmacies.

Downloads

Download data is not yet available.

References

Diabetes Atlas Comité; Internacional Diabetes Federation. Diabetes Atlas - Executive Summary. 2nd ed. Brussels (Belgium): International Diabetes Federation; 2003.

International Diabetes Federation Clinical Task Force; Internacional Diabetes Federation. Global Guideline for Type 2 Diabetes. Brussels (Belgium): International Diabetes Federation; 2005.

Direcção-Geral da Saúde; Ministério da Saúde. Programa Nacional de Prevenção e Controlo da Diabetes. Lisboa (Portugal): Ministério da Saúde; 2007.

Instituto Nacional de Estatística. Anuário Estatístico de Portugal 2005 – vol.1. Lisboa (Portugal): Instituto Nacional de Estatística; 2006.

Department of Noncommunicacle Disease Management; World Health Organization. Screening for Type 2 Diabetes - Report of a World Health Organization and International Diabetes Federation meeting. Geneva (Switzerland): World Health Organization; 2003.

American Diabetes Association. Screening for Type 2 Diabetes. Diabetes Care. 2004;27(Suppl.1):S11-S14.

American Diabetes Association. The prevention or delay of type 2 Diabetes. Diabetes Care. 2002;25(4):742-9.

Grupo de Investigação em Cuidados Farmacêuticos; Universidade Lusófona de Humanidades e Tecnologias. Protocolo de Identificação de Suspeitos de Diabetes Tipo 2. Lisboa (Portugal): Universidade Lusófona de Humanidades e Tecnologias; 2005.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29(Suppl 1): S43-8.

Guerra MM, Fornos JA, Andres NF. Detección de diabéticos no diagnosticados en las farmacias comunitarias de la provincia de Pontevedra. Pharmaceutical Care España. 2003;5(4):166-9.

Arias JL, Linares FM, Santamaría JM. Detección de posibles diabéticos no diagnosticados en una farmacia comunitaria. Ars Pharmaceutica. 2007;48(2):187-200.

Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, et al. Pharmacy-and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006; 46(3):370-7.

Hersberger KE, Botomino A, Mancini M, Bruppacher R. Sequential screening for diabetes - evaluation of a campaign in Swiss community pharmacies. Pharm World Sci. 2006;28(3):171-9.

Downloads

Published

2007-12-20

How to Cite

1.
PILGER D, SANTOS H, FINO M, CAETANO M, FAUS M, IGLÉSIAS P. Detection of undiagnosed cases of diabetes type 2 in patients with risk factors at community pharmacies of Portugal. Ars Pharm [Internet]. 2007 Dec. 20 [cited 2024 Jul. 22];48(4):387-96. Available from: https://revistaseug.ugr.es/index.php/ars/article/view/5013

Issue

Vol. 48 No. 4 (2007)

Section

Original Articles

License

The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:

  1. The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.

b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.

c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).